E-LIB Suche - Ergebnisse für: Yamano, Yoshinori

1

In vitro activity of cefiderocol against MBL-producing Gram..:

Takemura, Miki ; Wise, Mark G ; Hackel, Meredith A..
Journal of Antimicrobial Chemotherapy. 78 (2023) 8 - p. 2019-2027 , 2023

Link: https://doi.org/10.1093/..

2

603. Determining Effect of Media and Disk Source on Reprodu..:

Takemura, Miki ; Saiki, Mizue ; Yamashiro, Hidenori...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

3

In vitroandin vivoactivity of cefiderocol againstAchromobac..:

Takemura, Miki ; Nakamura, Rio ; Ota, Merime...
Antimicrobial Agents and Chemotherapy. 67 (2023) 12 - p. , 2023

Link: https://doi.org/10.1128/..

4

Heteroresistance to cefiderocol in carbapenem-resistantAcin..:

Longshaw, Christopher ; Santerre Henriksen, Anne ; Dressel, Dana...
Microbiology Spectrum. 11 (2023) 6 - p. , 2023

Link: https://doi.org/10.1128/..

5

Cefiderocol Treatment for Patients with Multidrug- and Carb..:

Satlin, Michael J. ; Simner, Patricia J. ; Slover, Christine M....
Antimicrobial Agents and Chemotherapy. 67 (2023) 7 - p. , 2023

Link: https://doi.org/10.1128/..

6

2762. Activity of Cefiderocol and Comparator Agents Against..:

DeJonge, Boudewijn L ; Nguyen, Sean T ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

2790. Activity of Cefiderocol and Comparator Agents Against..:

Nguyen, Sean T ; DeJonge, Boudewijn L ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

In vivoefficacy & resistance prevention of cefiderocol in c..:

Gill, Christian M ; Santini, Debora ; Takemura, Miki...
Journal of Antimicrobial Chemotherapy. 78 (2023) 4 - p. 983-990 , 2023

Link: https://doi.org/10.1093/..

9

Prospective role of cefiderocol in the management of carbap..:

Kollef, Marin ; Dupont, Herve ; Greenberg, David E....
International Journal of Antimicrobial Agents. 62 (2023) 2 - p. 106882 , 2023

Link: https://doi.org/10.1016/..

10

2791. Antimicrobial Activity of Cefiderocol and Comparator ..:

Nguyen, Sean T ; Valencia, Calbert ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

2112. In vitro Activity of Cefiderocol and Comparator Agent..:

Bryowsky, Jason J ; DeJonge, Boudewijn L ; Nguyen, Sean T...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

12

In vitroefficacy of humanized regimen of flomoxef against e..:

Yamashiro, Hidenori ; Kasamatsu, Yu ; Anan, Naomi...
Antimicrobial Agents and Chemotherapy. 67 (2023) 9 - p. , 2023

Link: https://doi.org/10.1128/..

13

In vitro antibacterial activities of cefiderocol against Gr..:

Kohira, Naoki ; Hackel, Meredith A ; Oota, Merime...
Journal of Global Antimicrobial Resistance. 32 (2023) - p. 181-186 , 2023

Link: https://doi.org/10.1016/..

14

2761. Activity of Cefiderocol and Comparator Agents Against..:

DeJonge, Boudewijn L ; Nguyen, Sean T ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

15

Assessment of sustained efficacy and resistance emergence u..:

Gill, Christian M. ; Abdelraouf, Kamilia ; Oota, Merime...
JAC-Antimicrobial Resistance. 4 (2022) 3 - p. , 2022

Link: https://doi.org/10.1093/..